Inactive Instrument

GENS UNICPAR Share Price

Equities

GENQ

US37187C1009

Dynamic Chart
Genesis Unicorn Capital Corp.(NasdaqGM:GENQ) dropped from NASDAQ Composite Index CI
Environmental Solutions Group Holdings Limited acquired Genesis Unicorn Capital Corp. from a group of shareholders in a reverse merger transaction. CI
Environmental Solutions Group Holdings Limited Enters Joint Development Agreement with Nanomatics Pte Ltd CI
Genesis Unicorn Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Genesis Unicorn Capital Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Genesis Unicorn Capital to Merge With Environmental Solutions Group Holdings MT
Genesis Unicorn Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Certain Class B Common Stock of Genesis Unicorn Capital Corp. are subject to a Lock-Up Agreement Ending on 13-AUG-2022. CI
Genesis Unicorn Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Genesis Unicorn Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Genesis Unicorn Capital Corp. Reports Earnings Results for the Ten Months Ended December 31, 2021 CI
Genesis Unicorn Capital Corp. Auditor Raises 'Going Concern' Doubt CI
Genesis Unicorn Capital Corp.(NasdaqGM:GENQ) added to NASDAQ Composite Index CI
Genesis Unicorn Capital Corp. Announces Board Appointments CI
Genesis Unicorn Capital Corp. announced that it has received $3.77331 million in funding from Genesis Unicorn Capital, LLC CI
More news
Genesis Unicorn Capital Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It has not selected any specific business combination target and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company intend to focus its search on the intersection of the healthcare and technology industries, specifically within the biotechnology and pharmaceutical sectors. The Company neither engages in any business operations nor generates any revenues.
Sector
-
More about the company